MedPath

Evaluation of the effect of progesterone on latency period of preterm premature rupture of membrane

Phase 2
Conditions
preterm premature rapture of membrane in pregnant women.
Premature rupture of membranes
Registration Number
IRCT2014020216453N1
Lead Sponsor
Research chancelor of kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
171
Inclusion Criteria

obvious fluid passage or direct observation with speculum or by positive nitrazine test in gestational age of 24 to 34 week - according to first trimester sonography or last menstrual period.
Exclusion criteria: anomalous fetus? multiple gestation? chorioamnionitis signs at the time of admission? fetal distress? abruptio placenta? placenta previa? IUGR? medical diseases of mother (DM, severe preeclampsia).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath